New Products/Product News
Articulating External Fixator for Foot Surgery
Wright Medical Group, Inc., has announced the launch of its patent- pending CORETRAK™ Articulating External Fixator. The company notes that the CORETRAK articulating fixator design is well-suited for challenging fixation cases of the foot, such as those involving diabetic patients.
Wright’s CORETRAK articulating fixator design simplifies the procedure for the surgeon, the patient, and hospital staff. The device also addresses a growing need for minimally invasive solutions that respect the body’s natural ability to heal, which is particularly important for the growing population of diabetics who are already at a high risk for surgical complications.
The CORETRAK Articulating Fixator is provided in a sterile packaged procedure kit to save surgical facilities the time and expense of cleaning and sterilizing. The kits may also be useful for military and emergency operations where time is critical.
For more information, contact
Wright Medical Technology, Inc.
|
Vertebral Body Replacement Device
| Medtronic, Inc., has announced the launch of the T2 SCEPTOR™ Distractible End Cleats System, a vertebral body replacement device intended for use in the thoracic and lumbar spine (T1–L5) to replace a vertebral body that is collapsed, damaged, or unstable owing to tumor or trauma.
Used in conjunction with PYRAMESH® C Surgical Titanium Mesh, the T2 SCEPTOR Distractible End Cleats System provides increased surface area and end-plate contact to help decrease the risk of dislodging postoperatively. The system features multiple end cap angles and a broad range of sizes to accommodate individual patient anatomy. Coinciding with this launch, Medtronic is also introducing a new Round Mesh Cutter that provides a smoother and more consistent mesh cut than traditional mesh trimmers.
The T2 SCEPTOR Distractible End Cleats System must be used in conjunction with PYRAMESH C Titanium centerpieces and with additional anterior and/or posterior spinal instrumentation to augment stability.
To learn more, contact
Medtronic
|
DNA-Based Orthobiologics Product
Cardium Therapeutics has announced plans to develop a DNA-based orthobiologics product portfolio based on research and development by Cardium’s Tissue Repair Company that will initially focus on nonunion bone fractures for medically compromised patients and spinal fusion for pat |